These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36545453)

  • 21. Protection by metformin against severe Covid-19: An in-depth mechanistic analysis.
    Wiernsperger N; Al-Salameh A; Cariou B; Lalau JD
    Diabetes Metab; 2022 Jul; 48(4):101359. PubMed ID: 35662580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients.
    Hasan SS; Kow CS; Bain A; Kavanagh S; Merchant HA; Hadi MA
    Expert Opin Pharmacother; 2021 Feb; 22(2):229-240. PubMed ID: 33054481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin is associated with favorable outcomes in patients with COVID-19 and type 2 diabetes mellitus.
    Ma Z; Patel N; Vemparala P; Krishnamurthy M
    Sci Rep; 2022 Apr; 12(1):5553. PubMed ID: 35365744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin Use, Diabetes Control, and Outcomes in Patients with COVID-19.
    Riahi S; Sombra LRS; Lo KB; Chacko SR; Neto AGM; Azmaiparashvili Z; Patarroyo-Aponte G; Rangaswami J; Anastasopoulou C
    Endocr Res; 2021; 46(2):45-50. PubMed ID: 33275067
    [No Abstract]   [Full Text] [Related]  

  • 25. Anti-Inflammatory Potential of the Anti-Diabetic Drug Metformin in the Prevention of Inflammatory Complications and Infectious Diseases Including COVID-19: A Narrative Review.
    Plowman TJ; Christensen H; Aiges M; Fernandez E; Shah MH; Ramana KV
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19.
    Lalau JD; Al-Salameh A; Hadjadj S; Goronflot T; Wiernsperger N; Pichelin M; Allix I; Amadou C; Bourron O; Duriez T; Gautier JF; Dutour A; Gonfroy C; Gouet D; Joubert M; Julier I; Larger E; Marchand L; Marre M; Meyer L; Olivier F; Prevost G; Quiniou P; Raffaitin-Cardin C; Roussel R; Saulnier PJ; Seret-Begue D; Thivolet C; Vatier C; Desailloud R; Wargny M; Gourdy P; Cariou B;
    Diabetes Metab; 2021 Sep; 47(5):101216. PubMed ID: 33309936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.
    Aggarwal A; Shrivastava A; Kumar A; Ali A
    J Assoc Physicians India; 2020 Jul; 68(7):19-26. PubMed ID: 32602676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk Factors for Poor Outcomes of Diabetes Patients With COVID-19: A Single-Center, Retrospective Study in Early Outbreak in China.
    Zhang N; Wang C; Zhu F; Mao H; Bai P; Chen LL; Zeng T; Peng MM; Qiu KL; Wang Y; Yu M; Xu S; Zhao J; Li N; Zhou M
    Front Endocrinol (Lausanne); 2020; 11():571037. PubMed ID: 33071977
    [No Abstract]   [Full Text] [Related]  

  • 29. Characteristics, Management, and Outcomes of Elderly Patients with Diabetes in a Covid-19 Unit: Lessons Learned from a Pilot Study.
    Ricchio M; Tassone B; Pelle MC; Mazzitelli M; Serapide F; Fusco P; Lionello R; Cancelliere A; Procopio G; Lio E; Trecarichi EM; Torti C; Irace C
    Medicina (Kaunas); 2021 Apr; 57(4):. PubMed ID: 33916210
    [No Abstract]   [Full Text] [Related]  

  • 30. Differences in the Clinical and Hematological Characteristics of COVID-19 Patients with and without Type 2 Diabetes.
    Sun Y; Zhao R; Hu Z; Wang W; Wang S; Gao L; Fei J; Jian X; Li Y; Zheng H; Hou X; Chen L
    J Diabetes Res; 2020; 2020():1038585. PubMed ID: 33376750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 in diabetic patients: Related risks and specifics of management.
    Orioli L; Hermans MP; Thissen JP; Maiter D; Vandeleene B; Yombi JC
    Ann Endocrinol (Paris); 2020 Jun; 81(2-3):101-109. PubMed ID: 32413342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin-associated lactic acidosis and acute kidney injury in the era of COVID-19.
    Vordoni A; Theofilis P; Vlachopanos G; Koukoulaki M; Kalaitzidis RG
    Front Biosci (Schol Ed); 2021 Dec; 13(2):202-207. PubMed ID: 34879472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment Patterns in Patients With Newly Diagnosed Type 2 Diabetes in China: A Retrospective, Longitudinal Database Study.
    Wang C; Gao Y; Zhu L; Huang M; Wu Y; Xuan J
    Clin Ther; 2019 Aug; 41(8):1440-1452. PubMed ID: 31155146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapy of Type 2 Diabetes in Patients with SARS-CoV-2 Infection.
    Bielka W; Przezak A; Pawlik A
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective chart review of children with type 2 diabetes mellitus evaluating the efficacy of metformin vs. insulin vs. combination insulin/metformin.
    Meyer SL; Hoffman RP
    South Med J; 2011 Oct; 104(10):684-8. PubMed ID: 21941156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidiabetic Treatment before Hospitalization and Admission Parameters in Patients with Type 2 Diabetes, Obesity, and SARS-CoV-2 Viral Infection.
    Reștea PA; Mureșan M; Voicu A; Jurca T; Pallag A; Marian E; Vicaș LG; Jeican II; Crivii CB
    J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of metformin on mortality and severity in COVID-19 patients with diabetes mellitus.
    Yang W; Sun X; Zhang J; Zhang K
    Diabetes Res Clin Pract; 2021 Aug; 178():108977. PubMed ID: 34302912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis.
    Bramante CT; Ingraham NE; Murray TA; Marmor S; Hovertsen S; Gronski J; McNeil C; Feng R; Guzman G; Abdelwahab N; King S; Tamariz L; Meehan T; Pendleton KM; Benson B; Vojta D; Tignanelli CJ
    Lancet Healthy Longev; 2021 Jan; 2(1):e34-e41. PubMed ID: 33521772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Association Between Antidiabetic Agents and Clinical Outcomes of COVID-19 Patients With Diabetes: A Bayesian Network Meta-Analysis.
    Chen Y; Lv X; Lin S; Arshad M; Dai M
    Front Endocrinol (Lausanne); 2022; 13():895458. PubMed ID: 35692410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.
    Lancet; 1998 Sep; 352(9131):854-65. PubMed ID: 9742977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.